Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|September 17, 2025
Coffee for the liver: a mechanistic approachEduardo E Vargas-Pozada, Erika Ramos-Tovar, Linda Vanessa Márquez-Quiroga, et al.
Canadian Journal of Physiology and Pharmacology|February 6, 2023
The antioxidant and anti-inflammatory activities of caffeine effectively attenuate nonalcoholic steatohepatitis and thioacetamide-induced hepatic injury in male ratsEduardo E Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, et al.
Iranian Journal of Basic Medical Sciences|April 17, 2024
Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?Lourdes Graciela Baeza-Pérez, Sandra Edith Cabrera-Becerra, Rodrigo Romero-Nava, et al.
Oxidative Medicine and Cellular Longevity|June 1, 2018
Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 UpregulationErika Ramos-Tovar, Erika Hernández-Aquino, Sael Casas-Grajales, et al.
Toxicology Mechanisms and Methods|August 2, 2023
Serum α-SMA is a potential noninvasive biomarker of liver fibrosisIrina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, et al.
Annals of Hepatology|July 17, 2020
Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosisErika Hernández-Aquino, Marco A Quezada-Ramírez, Angélica Silva-Olivares, et al.
Phytotherapy Research : PTR|September 26, 2018
Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF-κB, Nrf2, transforming growth factor beta, Smad7, and hepatic stellate cell activationErika Ramos-Tovar, Rosa E Flores-Beltrán, Silvia Galindo-Gómez, et al.
Basic & Clinical Pharmacology & Toxicology|December 19, 2018
Stevioside inhibits experimental fibrosis by down-regulating profibrotic Smad pathways and blocking hepatic stellate cell activationSael Casas-Grajales, Diana Alvarez-Suarez, Erika Ramos-Tovar, et al.
European Journal of Pharmacology|October 17, 2019
Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathwaysErika Hernández-Aquino, Marco A Quezada-Ramírez, Angélica Silva-Olivares, et al.
Pageof 3